ReviewPolydrug abuse: A review of opioid and benzodiazepine combination use
Introduction
Benzodiazepines and opioids are among the most frequently abused psychoactive drug classes in the world (Grytten, 1998, Joranson et al., 2000, Substance Abuse and Mental Health, 2008). Not surprisingly, the concomitant use of these two classes of drug has received the attention of researchers and physicians since the 1970s (KIeber and Gold, 1978). The goal of this review is to gain a better understanding of the motivations for, and consequences of their co-use. Using PubMed and PsycINFO we searched for English language articles on this topic published between 1970 and 2012. Various combinations of the following search terms were used: opioid, benzodiazepine, heroin, methadone, polydrug abuse, concomitant use, co-administration, prescription opioid, midazolam, valium, diazepam, alprazolam, flunitrazepam, pharmacological interactions, and epidemiology. With this method, we identified over 5000 publications. After the removal of duplicates, titles and/or abstracts were reviewed by the authors for relevance. Data from approximately 200 articles was included in this manuscript. This review and synthesis of that literature focuses on clinical studies investigating pharmacological interactions between opioids and BZDs and the epidemiology of their co-abuse. Clinical research is the focus of this paper. At times however, preclinical data are used to supplement these finding and support the authors’ supposition concerning the motivation and risks that underlie the combined use of opioids and BZDs.
This review begins with a brief overview of the abuse of each drug alone, followed by a review of clinical literature investigating how opioid and BZD drugs interact pharmacologically. Finally, we review reports relating to the prevalence and consequences of BZD and opioid co-abuse. It is our hope that this review will lead to a better understanding of: how these drugs interact pharmacologically, which populations are abusing these two drugs and why, the prevalence of their co-abuse, and the clinical implications of this behavior.
Section snippets
A brief overview of opioid abuse
The opioid class of drugs includes natural opiates (e.g., morphine, codeine, salvia divinorum), semi-synthetic opioids (e.g., heroin, oxycodone, hydromorphone, hydrocodone, salvanorin A), and synthetic opioids (e.g., methadone, buprenorphine, and fentanyl; National Institutes on Drug Abuse/U.S. Dept of Health and Human Services, 2009). Opioids have multiple actions: they alter body temperature, cause sedation, depress respiration, induce eating, decrease gastrointestinal transit, affect urinary
A brief overview on benzodiazepine abuse
Benzodiazepines are among the most frequently prescribed psychotropic drugs in the world (Coach, 1990). These drugs, whose core chemical structure is the fusion of a benzene and diazepine ring, act as positive allosteric modulators of the GABAA receptor complex. Benzodiazepines act to enhance the effects of GABA by increasing chloride (Cl−) flux and rate of channel opening. These drugs are a commonly used and effective treatment for anxiety disorders, and adjunctive treatment in several
Pharmacological interactions between opioids and benzodiazepines
A number of studies have attempted to elucidate the mechanisms underlying opioid and BZD co-abuse by examining how these two types of drugs interact with one another. Preclinical research has shown that opioids and BZDs exert significant modulatory effects upon one another (Duka et al., 1980, LaBuda and Fuchs, 2001, Lopez et al., 1990, Moroni et al., 1978, Poisnel et al., 2009, Rocha et al., 1993, Sasaki et al., 2002, Soria et al., 1991, Tien et al., 2007). One possible mechanism to explain
The co-abuse of benzodiazepines and opioids in humans
Research suggests that the abuse liability of BZDs may only be notable in certain clinical populations, specifically, recreational users of other drugs of abuse and detoxified alcoholics (Cole and Chiarello, 1990). Furthermore, the abuse of BZDs among patients maintained on opioid agonists such as methadone, and more recently, buprenorphine has been consistently reported in the literature (Barnas et al., 1992, Brands et al., 2008, KIeber and Gold, 1978). The prevalence of BZD use among
Complications of benzodiazepine and opioid co-abuse
Because BZD and opioid polydrug use appears to be common, it is important to investigate potential adverse events that may result. Polysubstance abuse has been found to be a significant predictor of drug overdose (Kerr et al., 2005). Data indicate that 62–72% of patients being treated for overdose had consumed more than one class of drug (Backmund et al., 1999, Darke et al., 1996). This percentage is even higher (71–98%) when only fatal overdoses are assessed (Cook et al., 1998, Grass and
Conclusions
Abundant evidence documents the significant co-use of BZDs and opioids. Opioids have considerable therapeutic utility yet their euphoric effects make them among the most commonly abused drugs in the world. In comparison to opioids, BZDs are believed to act as euphoriants in very limited settings and when administered alone, have less abuse liability. Drug users appear to have discovered that BZDs are able to enhance the positive subjective effects of opioids. As such, individuals may be
Role of funding source
Financial support for the preparation of this manuscript was provided by the U.S. National Institute on Drug Abuse (DA030446-01A, DA09236, DA016759, DA022222, and DA031022). However, NIDA had no role in the decision to submit or write this report.
Contributors
Dr. Jones constructed sections describing the basic pharmacology of opioids and benzodiazepines, their physiological interactions and prevalence of their co-use around the world. Dr. Mogali described the abuse of these two drugs in human populations, along with its clinical implications and dangers. Dr. Comer wrote sections describing the significance and impact of this research and synthesized the various sections into one cohesive manuscript. All authors have approved the final manuscript.
Conflict of interest
Only the authors listed are responsible for the content and preparation of this manuscript. The authors declare that over the past 3 years SDC, JDJ, and SM have all received compensation (in the form of partial salary support) from investigator-initiated studies supported by Reckitt-Benckiser Pharmaceuticals, Schering-Plough Corporation, Johnson & Johnson Pharmaceutical Research & Development, Endo Pharmaceuticals, and MediciNova. In addition, SDC has served as a consultant to the following
References (226)
- et al.
Self-administration of barbiturates and benzodiazepines: a review
Pharmacol. Biochem. Behav.
(1987) - et al.
Opioid dependence and addiction during opioid treatment of chronic pain
Pain
(2007) The benzodiazepine site of the GABAA receptor: an old target with new potential?
Sleep Med.
(2004)- et al.
Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates
Drug Alcohol Depend.
(2008) - et al.
Relative abuse of diazepam and oxazepam: prescription forgeries and theft/loss reports in Sweden
Drug Alcohol Depend.
(1986) - et al.
Benzodiazepine prescription for patients in opioid maintenance treatment in Norway
Drug Alcohol Depend.
(2007) - et al.
Akinesia after locally applied morphine near the nucleus raphe pontis of the rat
Neurosci. Lett.
(1984) - et al.
Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002–2004
J. Pain
(2005) - et al.
The benzodiazepines as drugs of abuse
J. Psychiatr. Res.
(1990) - et al.
The role of human drug self-administration in the development of medications
Drug Alcohol Depend.
(2008)
Minireview. Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior
Life Sci.
Levels and correlates of polydrug use among heroin users and regular amphetamine users
Drug Alcohol Depend.
Benzodiazepine use and HIV risk taking behavior among injecting drug users
Drug Alcohol Depend.
Polydrug dependence and psychiatric comorbidity among heroin injectors
Drug Alcohol Depend.
Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients
Drug Alcohol Depend.
Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies
Eur. J. Pharmacol.
Benzodiazepines modulate striatal enkephalin levels via a GABAergic mechanism
Life Sci.
Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial
Drug Alcohol Depend.
Abuse liability, behavioral pharmacology, and physical dependence potential of opioids in humans and laboratory animals: lessons from tramadol
Biol. Psychol.
Methadone-related deaths in Western Australia 1993–99
Aust. N. Z. J. Public Health
The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland)
Drug Alcohol Depend.
Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic
Drug Alcohol Depend.
A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002
J. Pain Symptom Manage.
Benzodiazepine and sedative use abuse by methadone maintenance clients
Drug Alcohol Depend.
Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
Toxicology
Midazolam attenuates the antinociception induced by d-serine or morphine at the supraspinal level in rats
Eur. J. Pharmacol.
Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver
Drug Alcohol Depend.
Exploring the opioid system by gene knockout
Prog. Neurobiol.
Deaths involving buprenorphine: a compendium of French cases
Forensic Sci. Int.
Naloxone blocks the anti-anxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review
Psychopharmacology
The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society
Clin. J. Pain
Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders
CNS Spectr.
French field experience with buprenorphine
Am. J. Addict.
Repeated dispensing of codeine is associated with high consumption of benzodiazepines
Nor. J. Epidemiol.
Intoxikationen Suchtkranker durch Drogen und psychotrope Substanzen
Notarzt
Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
Clin. Infect. Dis.
Opioid therapy for chronic pain
New Engl. J. Med.
The heroin prescribing debate: integrating science and politics
Science
Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference
J. Clin. Psychopharmacol.
Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic
Addiction
Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach
Isr. J. Psychiatry Relat. Sci.
The reinforcing properties of diazepam under several conditions in the rhesus monkey
Psychopharmacology
Reinforcing effect ofalfentanil is mediated by mu opioid receptors: apparent pA2 analysis
J. Pharmacol. Exp. Ther.
French Network of Centers for Evaluation and Information Pharmacodependence (CEIP). Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey
Drug Saf.
Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat
Hum. Exp. Toxicol.
The impact of benzodiazepine use on methadone maintenance treatment outcomes
J. Addict. Dis.
The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia
Med. J. Aust.
Case series of buprenorphine injectors in Kuala Lumpur, Malaysia
Am. J. Drug Alcohol Abuse
Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain
Addiction
Mechanism of action of benzodiazepines on GABAA receptors
Br. J. Pharmacol.
Cited by (502)
Correlates of overdose among 2711 people who use drugs and live in 7 rural US sites
2024, Drug and Alcohol DependenceLongitudinal polysubstance use patterns and non-fatal overdose: A repeated measures latent class analysis
2024, International Journal of Drug PolicyPolysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder
2023, Preventive Medicine Reports